Zoono Group Limited (AU:ZNO)
ASX:ZNO
ZNO Stock Chart & Stats
AU$0.08
<AU$0.01(8.00%)
At close: 4:00 PM EST
AU$0.08
<AU$0.01(8.00%)
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.18
Previous CloseN/A
Volume41.30K
Average Volume (3M)153.26K
Market Cap
AU$25.19M
Enterprise ValueAU$25.34M
Total Cash (Recent Filing)AU$475.33K
Total Debt (Recent Filing)AU$625.70K
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding406,211,760
10 Day Avg. Volume257,173
30 Day Avg. Volume153,260
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)3.62
Price to Sales (P/S)9.30
P/FCF Ratio-6.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Financial LeverageSustained low leverage provides structural solvency resilience and financial flexibility. With modest debt relative to equity the company has lower fixed financing obligations, reducing bankruptcy risk and making it easier to raise or reallocate capital to support operations or strategic initiatives over the medium term.
Established Product Portfolio In Infection-controlAn established antimicrobial product line addresses structural demand in hygiene and infection-control across multiple end markets. Diversified go-to-market channels (consumer, institutional, commercial) and repeat-use applications support recurring revenue potential and longer-term resilience versus single-use or cyclical products.
Recent Revenue RecoveryYear-over-year revenue growth indicates some commercial traction and product demand pickup from a small base. If sustained, consistent top-line growth can help absorb fixed costs, improve scale economics, and create a path toward margin recovery and internal cash generation over the coming quarters.
Bears Say
Persistent Negative Operating Cash FlowContinued operating cash burn is a durable structural weakness: the business has not generated positive internal cash flows, forcing reliance on external financing or equity issuance. This increases dilution risk and constrains reinvestment capacity, impeding sustainable scaling and operational stability.
Deep, Multi-year Losses And Negative MarginsSeverely negative gross and net margins reflect structural profitability issues in the core product economics or cost base. Persistent large losses erode retained capital, undermine return generation, and indicate the current business model has not yet proven it can achieve sustainable unit economics.
Material Equity ErosionSignificant erosion of shareholders' equity over several years reduces the balance-sheet buffer against shocks and limits capacity to fund growth organically. A weakened capital base increases dependency on external capital, heightening refinancing risk and potential shareholder dilution if losses persist.
Zoono Group Limited News
ZNO FAQ
What was Zoono Group Limited’s price range in the past 12 months?
Zoono Group Limited lowest share price was AU$0.03 and its highest was AU$0.18 in the past 12 months.
What is Zoono Group Limited’s market cap?
Zoono Group Limited’s market cap is AU$25.19M.
When is Zoono Group Limited’s upcoming earnings report date?
Zoono Group Limited’s upcoming earnings report date is Aug 20, 2026 which is in 135 days.
How were Zoono Group Limited’s earnings last quarter?
Zoono Group Limited released its earnings results on Feb 19, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is Zoono Group Limited overvalued?
According to Wall Street analysts Zoono Group Limited’s price is currently Overvalued.
Does Zoono Group Limited pay dividends?
Zoono Group Limited pays a Notavailable dividend of AU$0.03 which represents an annual dividend yield of N/A. See more information on Zoono Group Limited dividends here
What is Zoono Group Limited’s EPS estimate?
Zoono Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zoono Group Limited have?
Zoono Group Limited has 406,211,760 shares outstanding.
What happened to Zoono Group Limited’s price movement after its last earnings report?
Zoono Group Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.515%.
Which hedge fund is a major shareholder of Zoono Group Limited?
Currently, no hedge funds are holding shares in AU:ZNO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zoono Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.18%
12-Months-Change
Fundamentals
Return on Equity
-108.90%
Trailing 12-Months
Asset Growth
-23.69%
Trailing 12-Months
Company Description
Zoono Group Limited
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally. The company's products include hand sanitizers, textile applicators, mould remediation, and surface sanitizers. It serves airlines, healthcare, childcare, facilities management, transportation, education, and hospitality sectors. The company was incorporated in 1986 and is headquartered in Auckland, New Zealand.
Technical Analysis
Skin Elements Limited
―
Food Revolution Group Ltd.
―
Fiji Kava Limited
―
―
Nutritional Growth Solutions Ltd.
―
Options Prices
Currently, No data available
---